2022
DOI: 10.1097/hp.0000000000001644
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy

Abstract: Importance 177 Lu therapy as part of theranostic treatment for cancer is expanding but it can be a challenge for sites with limited radiation protection staff to implement the radiation safety program required for therapeutic nuclear medicine. Objective To increase the adoption of 177 Lu therapy, especially in smaller centers and clinics, by providing a collection of radiation safety best practices and operational experience. To provi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…A second gap we have encountered involves the lack of an evidence-based urinary incontinence management guideline for cancer patients undergoing radiopharmaceutical delivery. While professional societies have offered good clinical practice guidelines for patient care with regard to preparation of facilities at treatment center locations (Hope et al 2019; Capon et al 2023), there are no specific individualized recommendations for patient protection when urine contamination of the patient is of primary concern. As such, we have decided upon an assessment-action plan for urinary incontinence dependent on pretherapy patient clinical condition (see details in Table 1).…”
Section: Challenges and Opportunitiesmentioning
confidence: 99%
See 3 more Smart Citations
“…A second gap we have encountered involves the lack of an evidence-based urinary incontinence management guideline for cancer patients undergoing radiopharmaceutical delivery. While professional societies have offered good clinical practice guidelines for patient care with regard to preparation of facilities at treatment center locations (Hope et al 2019; Capon et al 2023), there are no specific individualized recommendations for patient protection when urine contamination of the patient is of primary concern. As such, we have decided upon an assessment-action plan for urinary incontinence dependent on pretherapy patient clinical condition (see details in Table 1).…”
Section: Challenges and Opportunitiesmentioning
confidence: 99%
“…Luthenium-177 has a half-life of about 6.5 d, elevating the risk of prolonged contamination if its liquid formulation is spilled, and contamination surveys must be performed prior to clearing treatment locations for upcoming patients. Administration of 177 Lu dotatate necessitates room preparation with prophylactic protective coverings as well as a strong recommendation for an adjoining toilet due to a patient’s desire to void frequently (although a nearby toilet is acceptable as long as it is dedicated to such patients during their stay; Cappon et al 2023). It might be advantageous to have treatment patients change into hospital gowns and slippers upon arrival in order to prevent contamination of personal clothing, shoes, or other possessions (Cappon et al 2023).…”
Section: Perspectives On Urinary Incontinence During Radiopharmaceuti...mentioning
confidence: 99%
See 2 more Smart Citations
“…Thirdly, cancer and its treatment drastically impact patients’ quality of life. Treatments such as chemotherapy, radiation therapy, 2 and surgery cause physical and emotional side effects that are debilitating and long-lasting. Fourthly, not all cancer types are preventable.…”
mentioning
confidence: 99%